# Fentanyl Citrate Injection: FDA shortage status > FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice. - Derived status: current - Source statuses: Current - FDA package records: 19 - Latest FDA row update: 08/13/2026 - Retrieved: 2026-08-22T15:54:11+00:00 ## FDA package and manufacturer records - Fresenius Kabi USA, LLC — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20) — FDA availability: Available — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50) — FDA availability: Unavailable — updated: 08/04/2026 - Fresenius Kabi USA, LLC — Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11) — FDA availability: Available — updated: 08/04/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25) — FDA availability: Available — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10) — FDA availability: Unavailable — updated: 08/13/2026 - Hikma Pharmaceuticals USA, Inc. — Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05) — FDA availability: Unavailable — updated: 08/13/2026 - Hospira, Inc., a Pfizer Company — Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31) — FDA availability: Limited Availability — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61) — FDA availability: Available — updated: 08/07/2026 - Hospira, Inc., a Pfizer Company — Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28) — FDA availability: Available — updated: 08/07/2026 ## Sources and formats - [FDA openFDA source](https://api.fda.gov/drug/shortages.json) - [Canonical HTML](https://citefacts.com/shortages/fentanyl-citrate-injection) - [JSON record](https://citefacts.com/shortages/fentanyl-citrate-injection.json)